• OPEN AN ACCOUNT
Indian Indices
Sensex
82,954.64 456.50
( 0.55%)
Global Indices
Nasdaq
49,410.74 -272.93
(-0.55%)
Dow Jones
6,881.90 -20.41
(-0.30%)
Hang Seng
56,838.27 -629.56
(-1.10%)
Nikkei 225
10,620.33 -65.85
(-0.62%)
Forex
USD-INR
90.70 0.01
(0.01%)
EUR-INR
107.23 -0.14
(-0.13%)
GBP-INR
122.83 -0.27
(-0.22%)
JPY-INR
0.59 0.00
(-0.51%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
99.2482659
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
94.18
411054.07
EPS(TTM)
Face Value()
Div & Yield %
18.19
1
0.93
 

Vinyas Innovative Technologies receives Rs 33-cr purchase order
Oct 24,2025
According to an exchange filing, the orders are for the manufacture and supply of PCBA and are scheduled to be executed over six months.

The company clarified that none of its promoters, promoter group, or group companies have any interest in the order, and the contract does not qualify as a related-party transaction.

Vinyas Innovative Technologies specializes in design, engineering, and electronics manufacturing services, catering to global original equipment manufacturers (OEMs) and original design manufacturers (ODMs) in the electronics sector. Its key product is printed circuit boards (PCBs).

On a full-year basis, the company's net profit surged 26.5% to Rs 19.42 crore on a 25% rise in revenue to Rs 396.64 crore in FY25 over FY24.

The counter shed 0.76% to Rs 1,210 on the NSE.